CAS NO: | 357336-20-0 |
规格: | ≥98% |
包装 | 价格(元) |
100mg | 电议 |
500mg | 电议 |
1g | 电议 |
Brivaracetam has been discontinued (DEA controlled susbtance). Brivaracetam (formerly known as UCB-34714 and UCB 34714; Briviact), is a chemical analogue of levetiracetam, is a racetam derivative with anticonvulsant/antiepileptic effects. It was approved in 2016 for the treatment of epilepsy.
纯度:≥98%
CAS:357336-20-0